Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-23

FDA Approved: DESVENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves a supplemental application for desvenlafaxine succinate from Alembic Pharmaceuticals Limited, enabling the marketing of a generic desvenlafaxine pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine succinate (Desvenlafaxine succinate)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)